iCell Neurons: These human iPS cell-derived brain cells, are now available for your research needs. Learn more...
Training: Master the use of iCell Cardiomyocytes by completing CDI's iCertification Program. Read more...
CDI’s iCell Cardiomyocytes were discussed during a recent American Journal of Physiology podcast. Authors describe published research detailing the electrophysiological characterization of iCell Cardiomyocytes
The Power of iPS Cell Technology: Any cell type. Any genetic background. Any quantity. These cells deliver. Read more...
With 100+ employees and >390 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research. Read more...
Jan 1, 2012
GEN:
Industrial Quantities of iPSCs Now Possible
Dec 13, 2011
Next Big Future:
Stem Cells Will Soon Be Harvested to Create Any Type of Human Cell
Dec 13, 2011
Press Release:
Cellular Dynamics Announces Commercial Launch of iCell Neurons for Neuroscience Drug Discovery
Dec 5, 2011
Press Release:
Roche, ChanTest Collaborate for Preclinical Cardiac Safety Testing of Drug compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument
|
iCell Cardiomyocytes |
|
iCell Endothelial Cells |
|
iCell Neurons |
|
iCell Hepatocytes (Coming 2012) |
Have a unique genotype? Ask about our custom iPS cell reprogramming and terminal cell differentiation products and services.
